TenNor Therapeutics (Suzhou) Limited

HK$66.00As of Sun 8 Nov 2026, 12:00 UTC
HKEX:6872Healthcare
Country Hong Kong
PE (Fwd) •••
TSR 10Y CAGR —
Div yield —
ROE —
Biotechnology
Beta (5Y) —
PE TTM —
TSR TTM —
Mkt cap HK$3.454B
ROIC —
SE Grade™
Value
Quality
Moat
Consensus
Reference
$71
7.62%
37.72%
Hold 9|6|1|11|1
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
1.00
1.12
1.07
1.02
34.77%
39.78%
21.50%
6.62%
Revenue¥M
415.0
408.7
400.9
412.1
(1.49%)
(3.22%)
(4.67%)
(0.13%)
Peers (US$440.5M)
Cap (US$)
PE
440.2M
212.0x
439.6M
29.51x
Capital
TTM
5Y
10Y
Leveragex
1.239
0.227
0.211
EBIT/Intx
0.133
0.275
0.272
Own earn%
50.55
115.29
117.76
Sh yield%
53.08
37.22
35.87
Owners
Insiders/Inst%
5.86
78.21
Short interest%
1.28
SBC / revenue%
5.92
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
3
Op margin range%
14–22
$1 testx
—
Incr. ROIC%
8